Affimed Logo
  • Science and Technology
    • ICE® (innate cell engager) Molecules
    • ROCK® Platform
    • Publications and Posters
  • Pipeline and Clinical Trials
  • About Us
    • Management Board
    • Supervisory Board
    • Scientific Advisory Board
    • Partners and Collaborators
  • News and Events
  • Innately Affimed
  • Investors
    • Webcasts and Corporate Presentation
    • Analyst Coverage
    • Share Information
    • SEC and Financial Reports
    • Corporate Governance Affimed
    • Annual General Meeting 2024
    • EGM 2024
    • Sustainability Affimed
    • Press Release Distribution
  • Careers
    • Culture
  • Contact
Menu

News and Events

See what’s new at Affimed

News

All categories
Earnings
Press Release
All years
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Affimed Reports Progress on Key Clinical Development Programs

October 15, 2019

Affimed to Participate in Investor Conferences in September

August 28, 2019

Affimed Reports Second Quarter 2019 Financial and Operational Results

August 7, 2019

Affimed Announces Second Quarter 2019 Financial Results and Corporate Update Conference Call on August 7, 2019

July 31, 2019

Affimed Added to the Russell 2000®, 3000® and Microcap Indexes

July 1, 2019

Affimed Announces Clinical Data Update on Lead Product Candidate AFM13 in CD30+ lymphoma at ICML 2019

June 24, 2019

Affimed to Present Data on AFM13 at the 15th International Conference on Malignant Lymphoma in Lugano, Switzerland

June 12, 2019

Affimed Announces Annual General Meeting of Shareholders

June 4, 2019

Affimed to Present at the Jefferies 2019 Healthcare Conference

May 29, 2019

Affimed Announces R&D Strategy to Focus on Innate Immunity Portfolio; Reports First Quarter 2019 Financial Results and Operational Progress

May 22, 2019

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35

Events

All
Scientific
Investors

There are no events planned at the moment.

WebcastsMore events

Affimed GmbH
Gottlieb-Daimler Straße 2
68165 Mannheim
Germany

Phone: +49 (0)621-56003-0
Fax: +49 (0)621-56003-649
email hidden; JavaScript is required

  • Affimed Science and Technology
    • ICE® (innate cell engager) Molecules
    • ROCK® Platform
    • Publications and Posters
  • About Us
    • Management Board
    • Supervisory Board
    • Scientific Advisory Board
    • Partners and Collaborators
  • News and Events
  • Investors
    • Webcasts and Corporate Presentation
    • Analyst Coverage
    • Share Information
    • SEC and Financial Reports
    • Press Release Distribution
    • Corporate Governance
  • Careers
    • Culture

© 2025 Affimed GmbH

  • Data Protection
  • Imprint
  • Contact